Melanoma-Targeted Chemothermotherapy and <i>In Situ</i> Peptide Immunotherapy through HSP Production by Using Melanogenesis Substrate, NPrCAP, and Magnetite Nanoparticles

<table>Synthesis and chemical structures of NAcCAP and NPrCAP and their tyrosinase kinetics.</table>

Journal of Skin Cancer

fig1

Figure 1

Figure 1: Melanoma-Targeted Chemothermotherapy and <i>In Situ</i> Peptide Immunotherapy through HSP Production by Using Melanogenesis Substrate, NPrCAP, and Magnetite Nanoparticles 

Figure 1 | Melanoma-Targeted Chemothermotherapy and In Situ Peptide Immunotherapy through HSP Production by Using Melanogenesis Substrate, NPrCAP, and Magnetite Nanoparticles 